Draig Therapeutics · 9 hours ago
Director Clinical Sciences
Greater Boston
Full-time
Hybrid
Director/Executive
6+ years expDraig Therapeutics is an exciting, rapidly growing clinical-stage biotech focused on transforming the treatment landscape for depression and neurological disorders. The Director of Clinical Sciences will provide scientific leadership across active and planned trials, ensuring protocol adherence and fostering strong relationships with key opinion leaders to enhance trial execution.
BiopharmaBiotechnologyClinical TrialsTherapeutics
Responsibilities
This role plays a key part in advancing Draig’s clinical pipeline by providing scientific leadership across active and planned trials
The individual will deliver hands-on scientific oversight of ongoing studies, including regular site visits to investigators to foster strong scientific engagement, ensure protocol adherence, and maintain clinical alignment
In addition, this position will cultivate and manage impactful scientific and business relationships with key opinion leaders (KOLs), helping to shape study strategy, enhance trial execution, and elevate Draig’s visibility within the broader medical community
Support the execution of clinical studies supporting Draig’s product pipeline:
Review and interpret clinical data on an ongoing basis to ensure data quality and interpretability, and scientific consistency
Participate in the blinded data review (BDA) of the clinical data
Conduct regular site visits to engage with investigators and site staff, build relationships, and ensure alignment with protocol objectives and scientific rationale
Collaborate closely with clinical operations, medical monitors, data management, biostatistics, and other functions (internal and external) throughout the lifecycle of the clinical trial
Contribute to the development of study synopsis, study protocols, clinical study reports, INDs, NDAs, and their related activities
Organize and participate in scientific advisory committees and KOL meetings
Support safety surveillance, including reviewing adverse events and participating in safety review meetings
Assist Clinical Operations in study site selection
Assist with the development of publications, abstracts, and presentations related to study data
Plan for the growth scenario within the functional group and may manage other Clinical Scientists members
Qualification
Required
a strong clinical background in neuroscience or psychiatry and thrives in a fast-paced biotech environment
Advanced degree (PhD, PharmD, MD, or equivalent) in a scientific or clinical discipline required; neuroscience or psychiatry focus strongly preferred
At least 6 years' experience in a Clinical Scientist role in the biotech or pharmaceutical industry
Management of people is a plus
For a Clinical Scientist, at least two years' experience in MDD
Experience supporting clinical development programs in psychiatry trials
Late-stage development (Phase 2/3) required
Willingness and ability to travel regularly (up to 30%) and, as directed by business needs, to clinical sites across the U.S. and Europe
Strong understanding of GCP and regulatory requirements
Experience interacting with clinical KOLs in psychiatry or CNS
Familiarity with depression scales (e.g., MADRS, HAM-D, PHQ-9)
Experience with digital endpoints, ePRO, or decentralized trials is a plus
Strategic thinker with excellent execution and communication abilities
Ability to work cross-functionally and independently in a fast-moving environment
Ability to work independently, with minimal supervision
Excellent communication and interpersonal skills
Strong problem-solving and decision-making abilities
Collaboration: Embodies and promotes collaboration and works effectively with others across the organization to achieve goals
Relationship Building: Establishes and maintains strong internal and external relationships
Preferred
neuroscience or psychiatry focus strongly preferred
Management of people is a plus
Experience with digital endpoints, ePRO, or decentralized trials is a plus
Company
Draig Therapeutics
Draig Therapeutics is a clinical-stage biopharmaceutical startup.
11-50 employees
Funding
Current Stage
Early StageTotal Funding
$140MKey Investors
Access Biotechnology
2025-06-18Series A· $140M
2024-09-01Seed
Leadership Team
Ivana Magovčević-Liebisch
President and CEO
Inderjit Kaul
Chief Medical Officer
Recent News
businessweekly.co.uk
2025-12-02
Minerva Neurosciences, Inc
2025-11-19
2025-11-09
Company data provided by crunchbase